Pulmonx Corporation
LUNG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $104,101 | $268,895 | $265,564 |
| - Cash | $76,549 | $75,466 | $74,555 | $70,905 |
| + Debt | $55,323 | $56,828 | $56,949 | $56,471 |
| Enterprise Value | – | $85,463 | $251,289 | $251,130 |
| Revenue | $21,502 | $23,859 | $22,538 | $23,765 |
| % Growth | -9.9% | 5.9% | -5.2% | – |
| Gross Profit | $16,052 | $17,204 | $16,342 | $17,590 |
| % Margin | 74.7% | 72.1% | 72.5% | 74% |
| EBITDA | -$12,778 | -$13,898 | -$14,563 | -$13,123 |
| % Margin | -59.4% | -58.3% | -64.6% | -55.2% |
| Net Income | -$13,957 | -$15,173 | -$14,448 | -$13,175 |
| % Margin | -64.9% | -63.6% | -64.1% | -55.4% |
| EPS Diluted | -0.34 | -0.38 | -0.36 | -0.33 |
| % Growth | 10.5% | -5.6% | -9.1% | – |
| Operating Cash Flow | -$8,162 | -$3,955 | -$13,222 | -$6,730 |
| Capital Expenditures | -$89 | -$49 | -$301 | -$111 |
| Free Cash Flow | -$8,251 | -$4,004 | -$13,523 | -$6,841 |